Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.



  • 2017 Lung Cancer SPORE Workshop

    2017 Lung Cancer SPORE Workshop

    Meeting News

    By Roy S. Herbst, MD, PhD The National Cancer Institute’s (NCI’s) Lung Cancer Specialized Programs of Research Excellence (SPORE) and their affiliates met June 21-22, 2017, to discuss current trends in translational lung cancer research, plan collaborations, and design new projects. The event was hosted by Yale Cancer Center, the Yale SPORE in Lung Cancer…


  • ESMO-IASLC European Lung Cancer Congress

    ESMO-IASLC European Lung Cancer Congress

    Meeting News

    The Heine Hansen Award recipient is IASLC Lung Cancer News Associate Editor Fabrice Barlesi, MD. His lecture will be “The Power of Multiple H.” “I’m unbelievably grateful to the ESMO and to the IASLC for this prestigious award, which honors not only me but all of the French teams that are diligently working in the…


  • Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary

    Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary

    Meeting News

    By C.A.I.R.O Journal Club Executive Board Posted: April 2018 In early February, the Critical Appraisal Initiative for Research in Oncology (C.A.I.R.O) Journal Club celebrated its fourth anniversary by hosting a Lung Cancer 360 Forum in the Bibliotheca Alexandrina. The Forum was a 2-day interactive educational event that gathered 205 senior and early-career oncology physicians and…


  • Targeted Therapies Meeting Focuses on Upcoming Research Advances in Lung Cancer

    Targeted Therapies Meeting Focuses on Upcoming Research Advances in Lung Cancer

    Meeting News

    By Chairs Suresh Ramalingam, MD, Paul Bunn, MD, PhD, Leora Horn, MD, MSc, and Roy Herbst, MD, PhD Posted: February 2018 Lung cancer research has reached an exciting point with the availability of a plethora of therapeutic strategies that have resulted in improved outcomes for patients. Recent advances include novel targeted therapies based on genomic…


  • Lung Cancer Immunotherapy Meeting to Discuss New Topics, Emerging Themes

    Lung Cancer Immunotherapy Meeting to Discuss New Topics, Emerging Themes

    Meeting News

    Posted: February 2018 During the past few years, improvements in the knowledge of immune system biology have dramatically changed the therapeutic paradigm for NSCLC. Pembrolizumab has been recently approved by regulatory agencies as an upfront agent for patients with advanced NSCLC with 50% or greater programmed cell death ligand 1 (PD-L1) expression, and recent data…


  • Inaugural Africa Conference: Finding Parallels Among Disparate Realities

    Inaugural Africa Conference: Finding Parallels Among Disparate Realities

    Meeting News

    New collaborative meeting to provide educational, scientific updates to diverse audience from Africa and the Middle East. By Joy Curzio, ILCN Managing Editor Posted: February 2018 As a global association, the IASLC understands the numerous variables, experiences, and perspectives that dictate a country’s or region’s ability to be a principal actor in scientific events. For…


  • 5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research

    5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research

    Meeting News

    By Monte M. Winslow, PhD Posted: February 2018 Over 4 rainy days in San Diego, California, more than 220 participants from 15 different countries heard presentations that spanned a very wide range of basic, translational, and clinical lung cancer research. This joint conference between the IASLC and the American Association for Cancer Research (AACR) was…


  • Studies Indicate Expanding Benefit of Checkpoint Inhibitors

    Studies Indicate Expanding Benefit of Checkpoint Inhibitors

    Meeting News

    By Cynthia L. Kryder, MS and Lori L. Alexander, MTPW, ELS, MWC Posted: December 2017 An oral abstract session at the IASLC World Conference on Lung Cancer (WCLC) 2017 drew a standing-roomonly crowd to hear updates on studies of 3 immunotherapy drugs: pembrolizumab, nivolumab, and atezolizumab, and their role in advanced non-small cell lung cancer…


  • Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru

    Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru

    Meeting News

    By Luis E. Raez, MD Posted: December 2017 Under the sponsorship of the IASLC, the Peruvian Association for Bronchology and Interventional Pulmonology (APBNI) organized a seminar on bronchoscopy ultrasound (EBUS) and navigational bronchoscopy in Lima, Peru, on July 21, 2017. IASLC members Dr. Pedro Garcia-Mantilla, a pulmonologist at the Guillermo Almenara Hospital in Lima, and…


  • IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology

    IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology

    Meeting News

    By Jyoti Patel, MD, and Heather A. Wakelee, MD Posted: December 2017 The IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology was held September 14-16, 2017 and brought together nearly 400 participants to discuss important topics in lung cancer prevention, detection, and care. The multidisciplinary nature of the meeting was most apparent in the initial…